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Many RNA viruses remodel intracellular membranes
to generate specialized sites for RNA replication.
Howmembranes are remodeled and what properties
make them conducive for replication are unknown.
Here we show how RNA viruses can manipulate
multiple components of the cellular secretory path-
way to generate organelles specialized for replication
that are distinct in protein and lipid composition from
the host cell. Specific viral proteinsmodulate effector
recruitment by Arf1 GTPase and its guanine nucleo-
tide exchange factor GBF1, promoting preferen-
tial recruitment of phosphatidylinositol-4-kinase IIIb
(PI4KIIIb) to membranes over coat proteins, yielding
uncoated phosphatidylinositol-4-phosphate (PI4P)
lipid-enriched organelles. The PI4P-rich lipid micro-
environment is essential for both enteroviral and flavi-
viral RNA replication; PI4KIIIb inhibition interferes
with this process; and enteroviral RNA polymerases
specifically bind PI4P. These findings reveal how
RNA viruses can selectively exploit specific elements
of the host to form specialized organelles where
cellular phosphoinositide lipids are key to regulating
viral RNA replication.INTRODUCTION
Viruses rely on their host for viability and replication. During
infection, the virus and host become engaged in a dynamic
duet, lasting from several hours to potentially years (in persistent
infections), in which the virus initiates spatio-temporally ordered
sequences of subcellular events, along the way dramaticallyaltering cellular architecture and physiology. The host cell not
only provides building blocks such as nucleotides and amino
acids for viral metabolism but also can provide a structural plat-
form for replication and viral assembly (Uetz et al., 2006). Many
RNA viruses and even some DNA viruses such as the poxviruses
rely on host intracellular membranes for replication (Miller and
Krijnse-Locker, 2008; Salonen et al., 2005). In particular plus-
strand RNA virus families, so called because upon infection their
RNA can be directly translated into protein by host machinery,
replicate and assemble on modified intracellular membranes
(Miller and Krijnse-Locker, 2008; Salonen et al., 2005). The group
of plus-strand RNA viruses includes many important human
pathogens like picornaviruses (such as the enteroviral genus
members poliovirus [PV] and Coxsackievirus B3 [CVB3], rhino-
virus, and hepatitis A), coronaviruses (SARS), and flaviviruses
(hepatitis C virus [HCV], Yellow Fever virus, Dengue Fever virus,
West Nile virus).
Cells infected with plus-strand RNA viruses undergo a
dramatic remodeling of their intracellular membranes, and
RNA replication frequently takes place on the cytosolic leaflet
of these remodeled membranes (Dales et al., 1965; Miller
and Krijnse-Locker, 2008; Salonen et al., 2005). Replication
membranes for picornaviruses, flaviviruses, and coronaviruses
appear to originate from the endoplasmic reticulum (ER) (Schle-
gel et al., 1996), whereas for togaviruses and nodaviruses the
endosomes/lysosomes and mitochondria are thought to be the
membrane source (Magliano et al., 1998). Some viral replication
enzymes have sequences that integrate into the host membrane
bilayer, such as NS4B, a polytopic membrane protein of HCV
(Lundin et al., 2003), and the 2B and 3A proteins of picornavi-
ruses (Richards and Ehrenfeld, 1990). Many, however, are
soluble proteins, whose mechanism of membrane association
is unknown.
Plus-strand RNA viruses are critically dependent on intracel-
lular membranes (Miller and Krijnse-Locker, 2008; Richards
and Ehrenfeld, 1990; Salonen et al., 2005), but the propertiesCell 141, 799–811, May 28, 2010 ª2010 Elsevier Inc. 799
of the replication membranes that are required to support viral
RNA replication have not been defined. It has been speculated
that membranes may limit diffusion of viral/host proteins and
viral RNA, thereby increasing the local concentration of reaction
elements; or that membranes may provide specific lipids that
participate in the replication reactions themselves (Miller and
Krijnse-Locker, 2008). A number of cellular factors have been
implicated in viral RNA replication; e.g., several high-throughput
siRNA screens have identified potential cellular factors whose
knockdown reduces flavivirus replication (including components
of the endosomal machinery, actin modulators, and phospho-
lipid-modifying enzymes such as phosphatidylinositol-4
kinases), although themechanismbywhich any of these proteins
might regulate replication is not known (Berger et al., 2009;
Borawski et al., 2009; Tai et al., 2009; Trotard et al., 2009; Vaillan-
court et al., 2009). For PV and CVB3, both members of the
enterovirus genus of the picornavirus family, we have shown
that GBF1, a guanine nucleotide exchange factor (GEF) of the
small Ras-family GTPase Arf1, was required for enteroviral
RNA replication (Belov et al., 2007; Lanke et al., 2009). GBF1
catalyzes GDP/GTP exchange on Arf1, stabilizing membrane
association, which in turn recruits various effectors to these
membranes (Altan-Bonnet et al., 2004; Niu et al., 2005). In unin-
fected mammalian cells, GBF1 and Arf1 are both localized to the
ER, ER-Golgi intermediate compartment (ERGIC), and the Golgi
apparatus. Arf1’s known major effectors at these sites include
coat proteins such as COPI complex and clathrin, which regulate
membrane budding, and phosphatidylinositol-4-kinase IIIb (PI4-
KIIIb), which catalyzes the production of phosphatidylinositol-4-
phosphate (PI4P) lipids at the membrane bilayer (Godi et al.,
1999; Altan-Bonnet et al., 2004; Lee et al., 2004).
Here we focus on the in situ properties of the viral RNA replica-
tion membranes in cells infected with plus-strand RNA viruses.
We demonstrate how remodeling of the host secretory pathway
by enteroviral replication proteins generates organelles with
unique protein and lipid composition geared for replicating viral
RNA. We show that a specific enteroviral protein modulates
effector recruitment by GBF1 and Arf1, promoting PI4KIIIb
recruitment to secretory organelle membranes. This leads to
disassembly of conventional secretory organelles and assembly
of ‘‘replication organelles’’ that are juxtaposed to ER exit sites.
PI4KIIIb at these organelle membranes produces a PI4P lipid
microenvironment, which facilitates membrane binding of en-
teroviral RNA polymerase and viral RNA synthesis. Finally, we
find that flaviviruses, specifically HCV, also induce and depend
on the PI4P lipid microenvironments for RNA replication. Thus
PI4KIIIb is a key cellular protein exploited by several plus-strand
RNA viruses for replication.
RESULTS
We first investigated the in situ properties of RNA virus replica-
tion sites during enteroviral infections. Two hours after infection
with CVB3, we were able to detect newly synthesized viral plus-
strand RNA molecules (by fluorescence in situ hybridization)
localized to the host secretory Golgi/trans-Golgi network (TGN)
compartments by colabelingwithArf1-GFP (Figure 1A), a fluores-
cent protein-tagged version of the host small GTPase Arf1,800 Cell 141, 799–811, May 28, 2010 ª2010 Elsevier Inc.which functionally mimics the native Arf1 GTPase in both unin-
fected and virally infected cells (Niu et al., 2005; Presley et al.,
2002; Figure S1A available online). Viral replication protein 3A,
a small tail-anchored membrane protein (Towner et al., 1996),
and 3Dpol, the RNA-dependent RNA polymerase (RdRp), both
components of the viral replication enzyme complex (Richards
and Ehrenfeld, 1990), were also localized to the Golgi apparatus
and TGN compartments (Figure 1A), signifying that these
compartments were sites of initial viral RNA synthesis.
By 4 hr post-infection, at the peak of enteroviral RNA replica-
tion, both viral RNA and viral replication enzyme levels rapidly
increase. At this stage, Arf1 GTPase, viral RNA, 3Dpol (Figure 1B,
4 hr p.i.), and other viral replication proteins (Figure S1B) were
all redistributed to discrete cytoplasmic structures, which we
term RNA replication organelles. These organelles persisted
until the death of the cell, 10 hr after start of infection, during
which time both viral RNA and viral protein levels continued to
increase at these structures (Figure 1B, 8 hr p.i.). Cellular
GBF1, the GEF for Arf1, which we have previously shown to be
required for enteroviral RNA replication, was colocalized with
Arf1 (Figure 1C, Movie S1) and viral RNA and replication
enzymes throughout infection (Figure 1D). The replication organ-
elles at 4 hr post-infection were formed adjacent to ER exit sites
as determined by antibody labeling of sec31, a component of
COPII coats, which are recruited by activated Sar1 GTPases to
the ER (Figure 1E). ER exit site number and distribution were
largely unaffected throughout infection (not shown). Further-
more, reduction in levels of GBF1 (>70% depletion) and Arf1
(>50% depletion) proteins with siRNA (Figure 1F; Figures S2A–
S2C) or transient expression of a dominant-negative, GTPase-
inactive Sar1 protein (Sar1 [T39N]) (Figure 1F), which is known
to block the formation of ER exit sites (Kuge et al., 1994),
inhibited by 70% (for Arf1), 80% (for GBF1), and 50%
(for Sar1T39N) the replication of enteroviral RNA molecules
(Figures 1F and 1G), whereas none of these treatments alone
had any effect on cell viability (Table S1). Thus secretory pathway
machinery GBF1, Arf1, and Sar1 proteins were all required for
or facilitated viral RNA replication. Note that in all siRNA treat-
ment or transient plasmid expression experiments, viral RNA re-
plicons, where the capsid protein-encoding sequences have
been replaced by Renilla luciferase, were transfected into cells
and assayed for bioluminescence as an indicator of viral RNA
replication, thereby avoiding complications in the interpretation
of data due to potential impact of any treatment on viral entry
or virus assembly steps.
Atypical Replication Organelles Formed at ER Exit Sites
for Viral RNA Replication
When we examined by high-resolution confocal imaging the
replication membranes formed at 4 hr, we found that neither
the coat proteins 3COPI (a component of the COPI coat
complex) and clathrin nor the clathrin adaptor g-adaptin, which
are all known Arf1 effectors required for sorting/budding of
cargo, including Golgi enzyme Galactosyltransferase (GalT),
were colocalized with Arf1 at these organelles (Figures 2A–2C).
Note that in uninfected cells Arf1 is colocalized at the Golgi/
TGN/ERGIC with each of these components (Figures S3A–
S3G). We assessed the colocalization between Arf1 and these
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Figure 1. Enteroviral RNA and Replication Machinery Are Localized to the Host Secretory Pathway Organelles
(A) Viral RNA and viral replication protein (3A, 3Dpol) subcellular distribution in early stages of CVB3 RNA replication.
(B) Viral RNA and viral replication protein (3A, 3Dpol) subcellular distribution at peak stages of CVB3 RNA replication. See also Figure S1.
(C) Arf1-RFP and GBF1-YFP dynamics in CVB3-infected HeLa cell. Confocal time-lapse images of single cell are presented. See also Movie S1.
(D) GBF1 and viral RNA are colocalized in HeLa cells during CVB3 infection.
(E) Replication organelles, at peak replication, form adjacent to ER exit sites.
(F) Arf1 and GBF1 facilitate viral RNA replication. CVB3 replicon assays in HeLa cells pretreated with siRNA against Arf1 or GBF1. Bar graph presents maximum
replication values for each condition, normalized to control samples transfectedwith nontargeting siRNA. Error bars are SEM from eight replicates for each condi-
tion (**p < 0.01). See also Figures S2A–S2C and Table S1.
(G) Functional ER exit sites facilitate viral RNA replication. PV replicon assays in HeLa cells transiently expressing Sar1[T39N] plasmid. Bar graph presents
maximum replication values, normalized to control samples transfected with GFP. Error bars are SEM from eight replicates for each condition (**p < 0.01).
See also Table S1. r.l.u% = relative light unit %. All fluorescence images were confocal images of optical slice thickness 1 mm. Scale bar, 10 mm.components, at the start (0 hr) and at 4 hr post-infection, by
calculating the Pearson correlation coefficients (Figure S4). In
infected cells COPI, clathrin, and g-adaptin were dispersedacross the cytoplasm while their total cellular levels remained
unchanged as determined by western blotting (not shown). The
lack of localization of these proteins to replication membranesCell 141, 799–811, May 28, 2010 ª2010 Elsevier Inc. 801
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Figure 2. Reorganization of Secretory
Pathway Organelles after Enteroviral In-
fection
HeLa cells (A) coexpressing Arf1-RFP/3COP-YFP;
expressing Arf1-GFP (B, C, E–I); or coexpressing
Arf1-RFP/GalT-YFP (see Movie S2) (D) were
infected with CVB3 for 4 hr. Cells in (B), (C), (E)–(I)
were fixed and coimmunostained with anti-GFP
and (B) anti-clathrin heavychain; (C) anti-g-adaptin;
(E) anti-GM130; (F) anti-TGN46; (G) anti-GGA1; (H)
anti-Rab1b; (I) anti-ERGIC53 antibodies. Arrows in
(A), (B), (C), and (D) indicate Arf1-labeled
membranes that do not label with 3COP-YFP, cla-
thrin, g-adaptin, and GalT-YFP, respectively. See
also Figures S3A–S3H and Figure S4.
All fluorescence images were confocal images of
optical slice thickness 1 mm. Scale bar, 10 mm.was surprising given that Arf1 is able to bind and hydrolyze GTP
at these sites (Belov et al., 2007) and hence a priori capable of
recruiting these effectors. Consistent with the absence of coats,
these organelles were not labeled with Golgi enzymes
(Figure 2D; Movie S2), which typically sort into GBF1/Arf1-
GTP/COPI membranes at the ERGIC and Golgi apparatus of
uninfected cells (Figure S3C) (Lanoix et al., 1999). COPI-depen-
dent membrane budding mediates anterograde transport from
the ERGIC and hence is required for the maintenance of the
Golgi apparatus (Lee et al., 2004). The absence of Golgi enzyme
GalT localization to these organelles suggested a disruption of
anterograde transport, and indeed at 4 hr post-infection the
Golgi apparatus was completely disassembled (Movie S2);
consistent with this, trafficking of secretory cargo to the cell
surface was blocked (Figures S3H and S3I). In addition, ER-
GIC/Golgi matrix protein GM130 (Figure 2E) and endosomal
components such as transferrin receptor (Figure S3J) were
also absent from these membranes. Nevertheless, these organ-
elles did contain a combination of other TGN, Golgi, and ERGIC
components including TGN46, GGA1, Rab1b proteins as well as
some ERGIC 53 (Figures 2F–2I; Figure S4). Recent studies have
found that depletion of COPI proteins from cells can result in
a loss of secretory pathway compartmentalization and the
formation instead of membrane-bound structures that contain
components of TGN, Golgi, and ERGIC proteins (Styers et al.,
2008). Similarly, our findings here suggest that decoupling
GBF1/Arf1 activity from COPI recruitment to membranes also
results in a complete reorganization of the secretory pathway
away from distinct separate conventional organelles.
PI4KIIIb Is a Component of Replication Organelles
during Enteroviral Infection
Phospholipid-modifying enzyme PI4KIIIb, which catalyzes the
production of PI4P lipids from PI (D’Angelo et al., 2008), is one802 Cell 141, 799–811, May 28, 2010 ª2010 Elsevier Inc.of the critical downstream effectors of
Arf1, recruited to and activated by Arf1
at the TGN and Golgi apparatus
membranes and required for membrane
trafficking (Balla and Balla, 2006; Godi
et al., 1999). Given the absence of COPIor clathrin effectors at GBF1/Arf1-labeled replication organelles,
we tracked the fate of PI4KIIIb during enteroviral infection.
Before infection, Arf1 and PI4KIIIb were colocalized at the Golgi
apparatus (Figure 3A, 0 hr), but at 4 hr post-infection, in striking
contrast to COPI and clathrin, PI4KIIIb remained colocalized with
Arf1 (Figure 3A, 4 hr). This was confirmed by calculation of its
Pearson coefficient, which showed no change between these
two time points (Figure S4). This localization remained for the
rest of the infection (Figure 3A, 6hr) and was correlated with
GBF1/Arf1 localization and activity, as Brefeldin A (BFA) treat-
ment, which inactivates GBF1/Arf1 (by stabilizing the GBF1/
Arf1-GDP complex) (Niu et al., 2005), dispersed Arf1 along with
PI4KIIIb (Figure 3B). Furthermore, PI4KIIIb was not just spatio-
temporally correlated with replication organelles but was in
a physical association with the viral replication enzyme complex.
Upon immunoprecipitation of PI4KIIIb from infected cells at 4 hr
post-infection, the enteroviral 3A, 3AB, 3CD, and 3Dpol proteins,
which are all components of the replication complex, coprecipi-
tated with it (Figure 3C). Importantly, TGN46, which was spatio-
temporally localized with Arf1 (and hence PI4KIIIb) (Figure 2F),
was not coprecipitated, indicating the specificity of the complex
between PI4KIIIb and the viral replication proteins. In addition,
immunoprecipitation with IgG alone did not precipitate PI4KIIIb
or any of the viral proteins (not shown).
Enteroviral 3A Protein Can Selectively Recruit PI4KIIIb
to Membranes
We next tested whether the CVB3 replication protein 3A could
induce the selective recruitment of PI4KIIIb to membranes
observed during enteroviral infection. Membrane-anchored 3A
proteins from CVB3 and PV have been documented to activate
Arf1 by binding GBF1 and are required for viral RNA replication
(Belov et al., 2007; Wessels et al., 2006; Lanke et al., 2009). At
low levels of transient expression, 3A-myc was localized to the
A B
C
Figure 3. PI4KIIIb Is Localized to Enteroviral
RNA Replication Organelles
(A) PI4KIIIb and Arf1 are colocalized throughout
CVB3 infection. HeLa cells expressing Arf1-GFP
infected with CVB3 were immunostained with
anti-PI4KIIIb and anti-GFP antibodies.
(B) GBF1/Arf1 inactivation leads to PI4KIIIb
dispersal. HeLa cells were infected with CVB3 for
4 hr and treated with 10 mg/ml of BFA for 30 min.
75% ± 5% (n = 10 cells) of PI4KIIIb-associated
fluorescence was dispersed upon BFA treatment.
(C) PI4KIIIb is in physical complex with viral repli-
cation enzymes. HeLa cell lysates from cells in-
fected with CVB3 or mock () for 4 hr were immu-
noprecipitated with anti-PI4KIIIb antibodies. Input
samples verifying the presence of TGN46 in the
lysates prior to immunoprecipitation are presented
in the bottom panel.
All fluorescence images were confocal images of
optical slice thickness 1 mm. Scale bar, 10 mm.Golgi apparatus as determined by colocalization with Golgin97
(Figure 4A), along with native GBF1 and Arf1 proteins (Figures
4B and 4C). Although GBF1/Arf1 was present at these struc-
tures, the levels of bCOP, a component of the COPI coat
complex, were decreased at these sites 2-fold compared to cells
not expressing 3A-myc (Figure 4D, arrow; Figure 4G) whereas
the total cellular bCOP levels were unchanged (data not shown).
Significantly, despite a decrease in bCOP levels at 3A-labeled
membranes, we found that PI4KIIIb was redistributed with an
3-fold increase to these membranes relative to cells where
3A was absent (Figure 4E, arrow; Figure 4G). In comparison,
recruitment to the Golgi of structurally homologous enzyme
PI4KIIIa was unaffected by 3A-myc expression (Figures 4F and
4G). In cells expressing high levels of 3A-myc, the Golgi appa-
ratus was disassembled and 3A was localized to discrete
membranes juxtaposed to ER exit sites that were labeled with
PI4KIIIb but lacked bCOP and Golgi enzymes (Figures S5A–
S5D)—a phenotype previously observed in CVB3-infected cells
(Figure 2A, Figure 3A). Hence 3A expression alone enhanced
the membrane recruitment of one Arf1 effector, PI4KIIIb,
over another, COPI, and caused disassembly of the Golgi appa-
ratus, thus mimicking specific aspects of the virally infected
phenotype.
PI4KIIIb Activity Regulates Viral RNA Synthesis
To determine whether PI4KIIIb kinase activity was required for
enteroviral RNA replication, we measured the effect of the small
molecule PIK93, which selectively inhibits PI4KIIIb (Knight et al.,
2006), and found that enteroviral RNA replication was signifi-
cantly reduced (Figures 5A–5C). RNA replication could be
inhibited at concentrations as low as 125 nM and when PIK93
was added at time points after start of replication, indicating
a requirement for PI4KIIIb activity throughout the replication
process; and PIK93, up to 2 mM, had little effect on cell viability
(Figures S6A–S6C). When we reduced PI4KIIIb levels with siRNA
(Figures 5D–5F; Figure S2A) or transiently expressed a kinase-dead PI4KIIIb (PI4KIIIb-KD) (To´th et al., 2006) (Figures 5G–5I),
both PV and CVB3 viral RNA replication were considerably
delayed (Figures 5F and 5I) and accumulated reduced viral
RNA levels compared to nontargeting siRNA or GFP-expressing
control cells. PI4 kinase activity and PI4P lipids have been impli-
cated in ER exit site maintenance (Blumental-Perry et al., 2006),
but we found no change in distribution or number of ER exit sites
in cells treated with PI4KIIIb siRNA whereas cells treated with
PI4KIIIa siRNA had50% reduction (Figure S7). Hence downre-
gulating PI4KIIIb activity—a kinase critical for PI4P lipid
synthesis—inhibited enteroviral RNA replication.
The inhibition of replication observed after reduction of
PI4KIIIb activity could be due to decreased viral RNA translation
or proteolytic processing of the viral polyprotein into viral replica-
tion enzymes; alternatively inhibition could result from a direct
effect on viral RNA synthesis. A block in any one or more of these
stages would result in the inhibition of viral RNA replication
observed (Figures 5A–5I). To distinguish among thesewe utilized
a cell-free assay where viral RNA translation and processing can
be uncoupled from viral RNA synthesis (Barton and Flanegan,
1993; Fogg et al., 2003). We found that inhibition of PI4KIIIb
kinase activity had no impact on viral RNA translation or its
subsequent proteolytic processing of the polytopic protein into
the individual viral replication proteins (Figure 5J). There was,
however, a >70% inhibition of viral RNA synthesis (Figure 5K).
Thus viral RNA synthesis is regulated by PI4KIIIb activity.
PI4P Lipid Microenvironment at Replication Organelles
Regulates Enteroviral RNA Replication
Given the localization of PI4KIIIb to replication organelles, and
the inhibition of replication after knockdown of PI4KIIIb activity,
we monitored the levels of cellular PI4P, a known lipid product
of PI4KIIIb activity, during infection with CVB3. PI4P levels
increased 5-fold within the first 4 hr of CVB3 infection
(Figure 6A). Notably levels of PIP2, which can be derived from
PI4P lipids, were not changed and even decreased during thisCell 141, 799–811, May 28, 2010 ª2010 Elsevier Inc. 803
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Figure 4. Enteroviral 3A Proteins Can Promote Selective PI4KIIIb
Recruitment over Coat Proteins
(A–F) Impact of 3A-myc ectopic expression on host secretorymachinery. HeLa
cells were immunostained with antibodies to myc-tag and native: (A) Golgin97,
a Golgi resident protein; (B) GBF1; (C) Arf1; (D) bCOP; (E) PI4KIIIb; (F) PI4KIIIa.
804 Cell 141, 799–811, May 28, 2010 ª2010 Elsevier Inc.time (data not shown). To test if PI4P lipids themselves, indepen-
dent of PI4KIIIb, regulated viral RNA replication, we ectopically
expressed in cells Sac1 phosphatase, which specifically
converts PI4P lipids back to PI (Blagoveshchenskaya et al.,
2008). The inhibition was only 40% (Figure 6B) likely due to
continued production of PI4P by endogenous PI4 kinase activity,
or because not all cells that were transfected with enterovirus
RNA were transiently expressing the Sac1 phosphatase.
We next determined if the PI4P lipids were localized to replica-
tion membranes. We utilized GFP-tagged FAPP1-PH proteins,
which are known to bind PI4P lipid-containing membranes in
the presence of Arf1 (Godi et al., 2004; To´th et al., 2006). We
coexpressed Arf1-RFP and FAPP1-PH-GFP and acquired
time-lapse confocal images of individual cells during infection
with CVB3 to monitor the distribution of both Arf1 and PI4P lipids
(Figure 6C; Movie S3). At the start of infection the major PI4P
pool in the cell was found at the Golgi/TGN compartment. By
4 hr post-infection, all the newly formed Arf1-labeled organelles
contained PI4P lipids (Figure 6C, 4 hr). The PI4P labeling was
independently confirmed by staining with antibodies to PI4P
lipids (data not shown).PI4KIIIb Activity Responsible for PI4P Lipid
Microenvironment at Replication Organelles
By acutely treating cells coexpressing FAPP1-PH-GFP and Arf1-
RFP with PIK93 inhibitor at 4 hr post-infection, we demonstrated
that the PI4P lipids at replication organelles were the products of
PI4KIIIb activity. Using time-lapse imaging, we followed the fate
of FAPP1-PH-GFP and Arf1-RFP within individual cells pre- and
post-PIK93 treatment. We found that within 30 min of PIK93
addition, 60% of the FAPP1-PH-GFP associated with replica-
tion organelles was lost whereas the Arf1-RFP pattern was
largely unaffected (Figures 6D and 6E). This demonstrated that
a significant fraction of the PI4P lipids at replication sites were
a product of PI4KIIIb activity and that Arf1 binding tomembranes
was not dependent on PI4P lipids. Furthermore it indicated that
the PI4P lipid microenvironment at these membranes was not
static but turning over, as in the absence of PI4 kinase activity,
the lipids were quickly lost from these sites. This could be due
to conversion back to PI, potentially as a result of endogenous
Sac1 phosphatase activity or transport out of replication
membranes. The lack of complete FAPP1-PH-GFP dispersal
upon PIK93 treatment also suggested that other PI4 kinase
family members might be harnessed for PI4P lipid synthesis as
well during infection at these sites.RNA Polymerase 3Dpol Binds PI4P Lipids
Enteroviral RNA is synthesized by viral replication complex
enzymes, which include the RdRp 3Dpol. The mechanism byArrows and asterisk in (D) and (E) indicate cells where 3A is either expressed
(arrow) or not (*). See also Figures S5A–S5D.
(G) Quantification of GBF1 (n = 15 cells); Arf1 (n = 9 cells); bCOP (n = 10 cells);
and PI4KIIIb (n = 13 cells) antibody fluorescence associated with 3A-labeled
membranes as (%) of their respective values at the Golgi apparatus of cells
not expressing 3A. Error bars are SEM (**p < 0.001).
All fluorescence images were confocal images of optical slice thickness
1 mm. Scale bar, 10 mm.
Figure 5. PI4KIIIb Activity Is Required for Enteroviral RNA Replication
(A and B) PIK93 block of PI4KIIIb activity inhibits CVB3 and PV RNA replication. CVB3 and PV replicon assays in cells treated with 500 nM and 1 mM PIK93 are
shown. Bar graphs present maximum replication values for CVB3 (A) and PV (B) with PIK93 treatment, normalized to control (DMSO) treatment. See also Figures
S6A–S6C.
(C) Kinetics of inhibition by PIK93 presented for the CVB3 replicon.
(D and E) Reduction of PI4KIIIb levels with siRNA inhibits CVB3 and PV RNA replication. CVB3 and PV replicon assays in HeLa cells; bar graphs present maximum
replication values for each condition, normalized to control (nontargeting) siRNA. See also Figure S2A.
(F) Kinetics of inhibition by PI4KIIIb siRNA presented for PV replicon.
(G and H) Expression of ectopic kinase-dead PI4KIIIb (PI4KIIIb-KD) inhibits CVB3 and PV replication. CVB3 and PV replicon assays in HeLa cells; bar graphs
present maximum replication values for each condition, normalized to control (GFP) plasmid ectopic expression.
(I) Kinetics of inhibition by PI4KIIIb-KD presented for the CVB3 replicon. Error bars in each CVB3 assay are SEM of six CVB3 samples and each PV assay is SEM
for eight PV samples. (**p < 0.01).
(J and K) PI4KIIIb activity regulates viral RNA synthesis. Cell-free PV RNA translation (J) and synthesis (K) assays performed in the presence of PIK93.which the soluble 3Dpol protein associates with membranes
and catalyzes the synthesis of viral RNA on these membranes
is unknown. Given the in vivo localization of the viral replication
complex proteins including 3Dpol to membranes enriched in
PI4P lipids (Figures 1A and 1B, Figure 6C), we tested whether
the 3Dpol protein had itself any affinity for PI4P lipids. We as-
sayed for binding of 3Dpol to PI4P lipids by incubating purified
recombinant 3Dpol with membrane strips spotted with different
cellular lipids including PI4P. We found that 3Dpol specifically
and preferentially bound to PI4P lipids over all other phospha-
tidylinositides and phospholipids (Figures 6F and 6G). Thus
3Dpol alone, independent of any of the other components of
the viral replication complex, has a high and specific affinity
for PI4P lipids that potentially can regulate both its binding
to cellular membranes and its subsequent RNA synthesis
activities.PI4P Lipid Microenvironment Regulates HCV RNA
Replication
Given that the PI4P lipid microenvironment was required for
enteroviral RNA replication, we next tested if any other plus-
strand RNA virus was similarly dependent. HCV, an enveloped
virus that is a member of the flaviviruses, assembles its replica-
tion enzymes and replicates its RNA on remodeled ER
membranes (Wo¨lk et al., 2008). We coimmunostained the
Huh7-derived liver cell line 3-5B(HCV), which contains autono-
mously replicating, subgenomic, dicistronic, selectable HCV
RNAs from the infectious HCV-N1b strain as well as expressing
HCV nonstructural proteins (Ikeda et al., 2002), with antibodies
against PI4P lipids and the HCV protein NS5A. NS5A, a
membrane-associated protein that is part of the HCV replication
complex of enzymes and is colocalized with HCV RNA mole-
cules (Wo¨lk et al., 2008), allowed us to identify the cellular viralCell 141, 799–811, May 28, 2010 ª2010 Elsevier Inc. 805
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Figure 6. PI4P Lipid Microenvironment within Replication Organelles Regulates both Enteroviral and Flaviviral RNA Replication
(A) Cellular PI4P lipid levels rise in CVB3 infection. Total cellular PI4P lipids were quantified over time. Error bars are SEM from duplicate samples
(**p < 0.01).
(B) Reduction in PI4P lipid levels inhibits enteroviral RNA replication. PV replicon assays in HeLa cells ectopically expressing Sac1 are shown. Inset: western blot
showing increase in Sac1 levels after 16 hr of ectopic expression. Bar graph presents maximum replication values, normalized to control (GFP) plasmid ectopic
expression. Error bars are SEM from eight replicates cells (**p < 0.01).
(C) PI4P lipids localize to enteroviral replication organelles. Time-lapse confocal images of single HeLa cell infected with CVB3, coexpressing FAPP1PH-GFP/
Arf1-RFP (see also Movie S3).
(D) PI4KIIIb activity is responsible for PI4P lipids at enteroviral replication organelles. Time-lapse confocal image of single HeLa cell coexpressing FAPP1-PH-
GFP/ARF1-RFP pre- and post-PIK93 treatment at 4 hr post-infection with CVB3.
(E) Quantification of FAPP1PH-GFP to Arf1-RFP fluorescence from (D) expressed as a ratio. Error bars are SEM from ten cells for each condition.
(F and G) PV RNA polymerase specifically and preferentially binds PI4P lipids. Purified recombinant 3Dpol enzyme was incubated with membrane strips that were
previously spottedwith different lipids. Antibodies detected 3Dpol binding. Two representative blots are shown. Binding was quantified and plotted in bar graph as
a ratio over background non-lipid spotted membrane from three different experiments for each lipid type.
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RNA replication sites. First by quantification of PI4P-associated
antibody fluorescence we found that 3-5B(HCV) cells, compared
to parental Huh7, had an 45% increase in the total cellular
levels of PI4P (Figure 6H). Second, whereas in the parental
Huh7 cells the PI4P lipid pool was localized to the perinuclear
Golgi apparatus/TGN region, in 3-5B(HCV) cells the abundant
PI4P lipids were found colocalized with NS5A at discrete
punctate sites all across the cytoplasm (Figure 6I, inset). Notably
PI4KIIIb reduction by siRNA knockdown (>90% by immunofluo-
rescence staining, not shown) had greater effect on lowering
PI4P levels within 3-5B(HCV) cells compared to PI4KIIIa reduc-
tion, though it is likely that both enzymes contribute to the
increased cellular PI4P levels (Figures 6J and 6K). Finally, to
test whether PI4P lipids were also required for HCV RNA replica-
tion, we measured the replication of HCV J6/JFH (p7-Rluc2A)
replicons (Jones et al., 2007) in Huh7 cells where we had
depleted the PI4P lipid pool by transiently expressing the Sac1
phosphatase either alone or in combination with catalytically
inactive PI4KIIIb-KD. HCV RNA replication was inhibited by
>50% when Sac1 was expressed alone, and the effect was
greater (70%) in the presence of PI4KIIIb-KD, as would be
predicted (Figure 6L, Sac+PI4KIIIbKD). Thus the PI4P lipid
microenvironment in the membrane is an important regulator of
both enteroviral and flaviviral RNA replication.
DISCUSSION
Here we demonstrate that both enteroviruses and flaviviruses
exploit host PI4KIIIb enzymes and replicate their respective viral
RNA on PI4P lipid-enriched membranes. Furthermore we show
that the enteroviral membrane protein 3A can reorganize the
host secretory trafficking pathway to enhance the recruitment
of PI4KIIIb to host membranes in order to generate a PI4P
lipid-enrichedmembranemicroenvironment to which the soluble
viral RdRp 3Dpol can bind.
Based on our findings we propose a model for the reorganiza-
tion of the secretory pathway in enteroviral infections, which
generates PI4P lipid-enriched replication organelles (Figure 7).
Here membrane-bound enteroviral 3A proteins bind and modu-
late host GBF1/Arf1 to enhance recruitment of PI4KIIIb to
membranes, over COPI and other coat proteins, where it will
catalyze the production of PI4P lipids, leading to the biogenesis
of a PI4P lipid-enriched membrane microenvironment that is
distinct from that in uninfected cells. This PI4P lipid-rich micro-
environment will in turn promote the recruitment and stabilization
on the membrane of the RdRp 3Dpol from the cytosolic pool.
3Dpol as part of a replication complex of 3A and several other(H) Cellular PI4P lipid levels rise in HCV replicating cells. Quantification of PI4P with
quantification within Huh7 cells. Error bars are SEM from ten cells for each cell t
(I) PI4P lipids localize to HCV replication membranes. PI4P lipid and NS5A protein
with anti-PI4P and anti-NS5A antibodies.
(J and K) PI4KIIIb is responsible for a significant fraction of PI4P lipids at HCV repli
PI4KIIIa siRNA. Cells were immunostained and quantified for PI4P lipids. Repres
was done on 20 cells for each siRNA treatment condition.
(L) Reduction of PI4P lipids inhibits HCV replication. HCV replicon assays cond
Sac1, PI4KIIIb-KD, or both plasmids are shown. Bar graph presents maximum re
bars are SEM from eight replicates of cells for each treatment condition (**p < 0.
All fluorescence images were confocal images of optical slice thickness 1 mm.viral proteins will then initiate RNA synthesis at thesemembranes
(Figure 7A).
Enteroviral RNA replication begins on existing PI4P lipid-con-
taining organelles including the Golgi and TGN, which have the
highest steady-state levels of this lipid in uninfected cells (Godi
et al., 1999) (Figure 7B, uninfected). Viral RNA replication is
a positive feedback loop, where newly synthesized viral RNA
molecules are translated into increasing amounts of viral
replication proteins including 3A, which then further replicate
viral RNA. Since 3A modulates GBF1/Arf1 effector recruitment,
its impact on GBF1/Arf1/coat/PI4KIIIb interactions will become
inescapable as its levels rise. The selective recruitment of
PI4KIIIb to membranes over COPI will eventually disrupt secre-
tory membrane trafficking and lead to Golgi disassembly by
decreasing anterograde transport from the ERGIC and intra-
Golgi trafficking, both COPI-dependent processes (Lee et al.,
2004) (Figure 7B, 2 hr). Furthermore 3A-bound membranes
emerging de novo from ER exit sites will develop into PI4P
lipid-enriched uncoatedmembranes (Figure 7B, 4 hr). In addition
to forming replication organelles, disruption of secretory path-
way integrity has been implicated in the suppression of cytokine
secretion andMHC-dependent antigen presentation (Deitz et al.,
2000), thus serving multiple functions for efficient enterovirus
replication and propagation.
Newly formed replication organelles have an atypical combi-
nation of host protein and lipids, including being enriched
in PI4P lipids and containing PI4KIIIb, TGN46, GGA1, Rab1b,
and ERGIC53, which in uninfected cells would be segregated
among different secretory compartments. Modulation of host
secretory machinery by viral proteins and its consequences
are highly complex. The localization of some components can
be explained through affinity for either PI4P lipids (e.g., GGA1)
or GBF1 (e.g., GGA1, Rab1b) (Monetta et al., 2007;Wang et al.,
2007). However GGA1 can bind clathrin and g-adaptin (Bonifa-
cino, 2004; Lefranc¸ois and McCormick, 2007) and GBF1 can
bind COPI (Deng et al., 2009), but neither COPI, clathrin, nor
g-adaptin are present at replication sites. Potentially the high
PI4P lipid microenvironment in conjunction with viral proteins
may modulate interactions among GBF1, Arf1, and specific
effectors, promoting the sorting/partitioning of some compo-
nents while deterring others.
Arf1 recruits a variety of effectors to membranes, yet little is
known on the mechanism of the selection process. ArfGEFs
not only facilitate Arf recruitment and activation but also regulate
effector selection: e.g., GBF1 can bind COPI and GGA proteins.
Which ArfGEF recruits PI4KIIIb is not known in uninfected
cells, but GBF1 in the context of 3A proteins may facilitate theanti-PI4P primary antibodies of 3-5B(HCV) cells, normalized as% of PI4P lipid
ype.
distribution in Huh7 and 3-5B(HCV) cells were determined by immunostaining
cation membranes. 3-5B(HCV) cells were treated with nontargeting, PI4KIIIb, or
entative images of groups of siRNA-treated cells are shown (J). Quantification
ucted with J6/JFH (p7-Rluc2A) replicons in Huh7 cells ectopically expressing
plication value normalized to control (GFP) plasmid ectopic expression. Error
01).
Scale bar, 10 mm.
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AB
Figure 7. Model for Secretory Pathway
Reorganization in Enteroviral Infections
(A) Tail-anchoredmembrane protein 3Abybinding
and modulating GBF1/Arf1 promotes PI4KIIIb
recruitment to the membrane bilayer at the
expense of coat protein COPI. Recruited PI4KIIIb
will catalyze the production of a PI4P lipid micro-
environment (red lipids) that will in turn facilitate
the recruitment of 3Dpol from the cytosolic pool
to the membrane and promote the synthesis of
viral RNA.
(B) Uninfected (0 hr): Steady-state exchange of
membranes, Golgi enzymes, and cargo through
bidirectional trafficking between the ERGIC and
Golgi/TGN compartments. Golgi enzymes and
cargo are sorted out of Sar1/COPII-labeled ER
exit sites into ERGIC compartments whereupon
GBF1/Arf1 and COPI coats mediate the traf-
ficking to and from the Golgi/TGN compartments.
PI4KIIIb enzymes are recruited to Golgi/TGN
membranes by Arf1 and catalyze the production
of PI4P lipids at these membranes.
2 hr: Upon infection, newly synthesized viral repli-
cation enzymes such as the membrane-bound 3A
target to and assemble on secretory organelle
membranes but concentrate and initiate viral
RNA synthesis on the Golgi/TGN membranes,
where the pre-existing (i.e., prior to infection)
steady-state pool of PI4P lipids facilitates viral replication protein assembly and RNA replication. Rising levels of 3A combined with its modulation of effector
recruitment by GBF1/Arf1 will enhance the recruitment of PI4KIIIb over COPI, leading to a decreased rate of anterograde transport out of the ERGIC and subse-
quent disassembly of the Golgi/TGN organelles.
4 hr: Enhanced recruitment of PI4KIIIb over COPI results in the formation of uncoated PI4P lipid-enriched organelles adjacent to ER exit sites. The PI4P lipid-
enriched microenvironment of these organelles facilitates the ongoing assembly of newly synthesized viral replication proteins such as RdRp 3Dpol and viral RNA
replication.recruitment of PI4KIIIb in infected cells, given that PI4KIIIb is
colocalized with GBF1 and coimmunoprecipitated with 3A
(Figures 3A and 3C), where the latter is known to bind GBF1
(Wessels et al., 2006). It also remains to be explored whether
GBF1, Arf1, or any other viral or host proteins may be stimulating
PI4KIIIb activity to reach the high PI4P lipid levels observed
during infection.
HCV, an enveloped flavivirus whose replication enzymes
are sequence- and structure-wise distinct from enteroviral
enzymes (Dubuisson et al., 2002), nevertheless depends on
PI4P lipid-enriched membranes and PI4KIIIb for replication
(Figures 6H–6L). Whereas most enteroviral infections disrupt
secretory trafficking, flaviviruses utilize the secretory pathway
to mature into virions and exit the cell (Mackenzie and West-
away, 2007). HCV RNA is replicated on remodeled ER
membranes whereas structural proteins are located to lipid
droplets (Miyanari et al., 2007). Through a complex assembly
process not yet understood virions bud out of the ER and are
released from the cell through exocytosis. The presence of
high levels of PI4P lipids at ER membranes, in addition to regu-
lating HCV RNA replication, could impact the organization and
kinetics of secretory trafficking and budding/export of HCV.
Indeed secretory trafficking is attenuated in HCV-infected cells
(Konan et al., 2003).
Inmammaliancells,PI4P lipids, themost abundantmonophos-
phorylated inositol phospholipids,werepreviously viewedonlyas
PIP2 precursors (D’Angelo et al., 2008). However independent808 Cell 141, 799–811, May 28, 2010 ª2010 Elsevier Inc.functions have recently emerged: several host proteins including
CERT, OSBP, and FAPP1/2 specifically bind PI4P lipids (Lem-
mon, 2008); and PI4P lipids regulate selective autophagy and
ER exit site biogenesis (Blumental-Perry et al., 2006; Yamashita
et al., 2006). PI4P lipids can locally change membrane curvature
(Ishiyamaet al., 2002;McMahonandGallop, 2005). PI4P lipid-en-
riched membranes during viral infection may generate high-
curvature membrane pockets to shield viral components from
host defense. Little is known about how soluble viral RNA poly-
merases are recruited to membranes. PI4P lipids may provide
docking sites to concentrate viral proteins for efficient RNA
synthesis. Enteroviral RdRp 3Dpol preferentially binds PI4P lipids
over all other cellular lipid components, and PI4P depletion
specifically perturbs viral RNA synthesis (Figure 5 and Figure 6).
This raises the possibility that enteroviruses rewire host secretory
machinery to generate PI4P lipid-enriched membranes to recruit
to and concentrate on membrane RNA polymerases. Further-
more,PI4P lipidbindingmayalso induceconformational changes
and modulate RdRp enzymatic activity. The phosphoinositide-
binding domain on 3Dpol is unknown and studies to identify the
lipid-binding site and investigate its occurrence across different
RdRps are underway.
In summary, we show that the PI4P lipid microenvironment
is an important facilitator of plus-strand viral RNA replication.
Enteroviruses reorganize the cellular secretory trafficking
machinery away from building conventional secretory organelles
to generate organelles whose membranes are enriched in PI4P
lipids. Cellular PI4 kinases are key players in this process. The
findings with both picornavirus and flavivirus family members
highlight the importance of PI4P lipids and PI4 kinases for viral
RNA replication and will instigate studies to determine how
widespread thisdependenceonPI4P lipids is amongRNAviruses
and the mechanism by which these lipids modulate viral RNA
synthesis machinery. Furthermore small molecules targeting
PI4 kinases, such as PIK93, may provide a basis for the design
of new classes of therapeutics against viral RNA replication.EXPERIMENTAL PROCEDURES
Live-Cell Imaging
All imaging was performed on a Zeiss LSM510META confocal laser scanning
confocal microscope (Carl Zeiss, USA) using high-magnification, high numer-
ical aperture objectives. Live cells were maintained on themicroscope stage in
a temperature, CO2, and humidity-controlled environmental chamber. Time-
lapse images were acquired every 5 min for the duration of infection.
Immunofluorescence and Analysis
Cells were plated on coverslips, fixed with 4% formaldehyde PBS solution,
permeabilized with 0.2% saponin, incubated with primary, and fluorophore-
tagged secondary antibodies, and mounted. Confocal images were obtained
and analyzed with Zeiss LSM or Image J software.
Fluorescence in Situ Hybridization
Alexa555-labeled CVB3 plus-strand RNA-specific probes were synthesized
using FISH Tag RNA kit (Invitrogen Corp., CA). For colocalization of CVB3
plus-strand RNA with Arf1 or GBF1, infected cells were fixed with 4% formal-
dehyde followed by overnight permeabilization with 70% ethanol. Cells were
rehydrated in SSC buffer and hybridized with RNA probes overnight in hybrid-
ization buffer. GBF1 or Arf1 was immunostained with primary and Alexa488-
labeled secondary antibodies in the absence of detergents.
PI4P Lipid Extraction and Quantification
Cells were harvested, PI4P extracted, spotted on nitrocellulose membrane
strips, and detected by FAPP1 protein-derived PI4P detectors followed by
secondary and tertiary antibodies as described in Dowler et al. (2002).
siRNA Transfection
Cells were seeded in 96-well plates (for the replicon assay) or 12-well plates for
western blot analysis to verify knockdown efficiency of proteins, 1 day before
siRNA transfection. Typically 50 nM of each siRNA was transfected via Dhar-
mafect1 (Dharmacon, CO) and incubated for 48 hr.
Replicon Assays
pRib-Rluc (CVB3), pXpA-RenR(PV), and J6/JFH (p7-Rluc2A) (HCV) plasmids
with Renilla luciferase gene as reporters in place of structural genes were
utilized to measure viral RNA replication. Plasmids were in vitro-transcribed
and RNAs transfected into HeLa or Huh7 cells grown in 96-well plates. Cells
were incubated with live-cell Renilla substrate and light signal was recorded
with multiwell plate reader at 15 min intervals up to 16 hr at 37C.
RNA Polymerase Lipid-Binding Assay
Recombinant PV polymerase (3Dpol) in pET26Ub-3Dwas purified as described
(Gohara et al., 1999). Lipid dot-blot strips were purchased (Echelon Biosci-
ences, UT). The strips were incubated in blocking buffer for 1 hr at room
temperature (RT) and then incubated in the same buffer with purified 3Dpol
overnight at 4C. The blots were then washed in TBST-50 buffer. To detect
lipid protein interactions, strips were incubated with anti-3Dpol antibody for
1 hr at RT. Blots were washed as before and incubated with anti-rabbit horse-
radish peroxidase for 1 hr at RT. 3Dpol bound to the lipids immobilized on the
membrane were visualized by incubating with chemiluminescent substrate.Cell-free Translation and Replication Assays
HeLa S10 extracts for translation-replication reactions were prepared and
utilized for in vitro RNA translation and replication reactions as described
(Barton and Flanegan, 1993; Fogg et al., 2003). Translation reaction mixtures
included in vitro-synthesized PV RNA transcripts in the presence of 2 mM
GuHCl to block replication. An aliquot from each translation reaction mixture
was mixed with Redivue [35S] methionine (Amersham GE, NJ), incubated,
and then resolved by SDS-PAGE for visualization of translation products. Total
membrane pellets from translation reactions were suspended in GuHCl free-
medium containing cyclohexamide and P32-CTP and replication reactions
were performed in the absence of any protein synthesis. Replicated PV RNA
was resolved on agarose gels, which were then exposed to film for detection
and quantification of PV RNA. PIK93 dissolved in DMSO was added to a final
concentration of 0.4 mM or 2 mM in both the translation and replication assay
stages; control reaction mixtures contained DMSO only.
Statistical Analysis
Data were expressed and plotted as means ± standard error of the mean
(SEM). Unpaired student’s t tests were used to compare the mean of control
and experimental groups. The actual p value and sample size of each experi-
mental group were provided in the respective figure legends.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, one table, and three movies and can be found with this article online at
doi:10.1016/j.cell.2010.03.050.
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